The stock of Teleflex Incorporated (NYSE:TFX) hit a new 52-week high and has $286.32 target or 3.00% above today’s $277.98 share price. The 6 months bullish chart indicates low risk for the $12.52 billion company. The 1-year high was reported on Jan, 19 by Barchart.com. If the $286.32 price target is reached, the company will be worth $375.69M more. The stock increased 0.97% or $2.68 during the last trading session, reaching $277.98. About 80,339 shares traded. Teleflex Incorporated (NYSE:TFX) has risen 24.36% since January 19, 2017 and is uptrending. It has outperformed by 7.66% the S&P500.
Halliburton Company provides a range of services and products to the upstream oil and natural gas industry worldwide. The company has market cap of $45.97 billion. The companyÂ’s Completion and Production segment offers production enhancement services, including stimulation and sand control services; and cementing services, such as bonding the well, well casing, and casing equipment. It has a 216.82 P/E ratio. It also provides completion tools that offer downhole solutions and services, including well completion services and products, intelligent well completions, liner hanger systems, sand control systems, and service tools; pressure control services comprising coiled tubing, hydraulic workover units, and downhole tools; and pipeline and process services, such as pre-commissioning and maintenance, subsea pipeline, conventional pipeline, and process services.
Since August 1, 2017, it had 0 insider purchases, and 5 sales for $840,650 activity. BABICH GEORGE JR had sold 2,500 shares worth $658,450. 200 Teleflex Incorporated (NYSE:TFX) shares with value of $48,376 were sold by Klasko Stephen K. M.D..
Teleflex Incorporated designs, develops, makes, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company has market cap of $12.52 billion. It offers vascular access products consisting of Arrow branded catheters and related devices for critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and withdrawal of blood samples; interventional access products that are used in dialysis, oncology, and critical care therapies; and anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand. It has a 50.81 P/E ratio. The firm also provides surgical products, such as ligating clips and fascial closure systems; bladeless access ports, sutures, and other surgical instruments; and single-use and reusable products for surgical procedures under the Deknatel, Pilling, Kmedic, Hem-o-lok, and Weck brands.
Among 11 analysts covering Teleflex (NYSE:TFX), 8 have Buy rating, 0 Sell and 3 Hold. Therefore 73% are positive. Teleflex had 31 analyst reports since July 31, 2015 according to SRatingsIntel. As per Friday, January 6, the company rating was upgraded by Jefferies. The rating was maintained by KeyBanc Capital Markets with “Hold” on Thursday, November 16. Jefferies maintained Teleflex Incorporated (NYSE:TFX) rating on Thursday, November 2. Jefferies has “Buy” rating and $295.0 target. The firm earned “Outperform” rating on Friday, September 8 by Leerink Swann. Deutsche Bank downgraded Teleflex Incorporated (NYSE:TFX) on Tuesday, November 14 to “Hold” rating. The stock of Teleflex Incorporated (NYSE:TFX) has “Buy” rating given on Friday, November 3 by Needham. Needham initiated the stock with “Buy” rating in Tuesday, March 7 report. The firm earned “Buy” rating on Friday, March 11 by Brean Capital. The firm earned “Buy” rating on Tuesday, September 5 by Needham. The firm earned “Buy” rating on Tuesday, October 10 by Jefferies.
Investors sentiment increased to 1.1 in 2017 Q3. Its up 0.11, from 0.99 in 2017Q2. It increased, as 23 investors sold Teleflex Incorporated shares while 114 reduced holdings. 49 funds opened positions while 102 raised stakes. 39.29 million shares or 3.24% less from 40.61 million shares in 2017Q2 were reported. Chatham Gp Incorporated accumulated 7,705 shares. Denali Advsrs Ltd Liability holds 3,100 shares or 0.12% of its portfolio. Deutsche Comml Bank Ag owns 88,841 shares. First Tru L P owns 52,758 shares or 0.03% of their US portfolio. Credit Suisse Ag invested in 60,846 shares or 0.01% of the stock. Guyasuta Inv Advsrs reported 4,695 shares. Moreover, Rowland And Com Counsel Adv has 1.03% invested in Teleflex Incorporated (NYSE:TFX) for 11,704 shares. Credit Agricole S A reported 47,349 shares or 0.04% of all its holdings. Rainier Inv Mgmt Limited Company accumulated 31,390 shares. Moreover, Hancock has 0.02% invested in Teleflex Incorporated (NYSE:TFX). Art Advsrs Ltd Liability invested in 0.07% or 5,400 shares. Capital Rech Global owns 494,791 shares. Southeast Asset Advisors reported 8,780 shares. Voya Invest Management Limited Liability has 18,973 shares for 0.01% of their portfolio. M&T Savings Bank holds 5,702 shares.
Analysts await Teleflex Incorporated (NYSE:TFX) to report earnings on February, 22. They expect $2.38 earnings per share, up 11.74% or $0.25 from last year’s $2.13 per share. TFX’s profit will be $107.22 million for 29.20 P/E if the $2.38 EPS becomes a reality. After $2.12 actual earnings per share reported by Teleflex Incorporated for the previous quarter, Wall Street now forecasts 12.26% EPS growth.
The stock increased 0.63% or $0.3277 during the last trading session, reaching $52.6877. About 3.48M shares traded. Halliburton Company (HAL) has risen 19.03% since January 19, 2017 and is uptrending. It has outperformed by 2.33% the S&P500.
Brenham Capital Management L.P. holds 11.02% of its portfolio in Halliburton Company for 1.75 million shares. Energy Opportunities Capital Management Llc owns 289,102 shares or 8.66% of their US portfolio. Moreover, Talara Capital Management Llc has 6.75% invested in the company for 282,277 shares. The New York-based Arosa Capital Management Lp has invested 6.36% in the stock. Bain Capital Credit Lp, a Massachusetts-based fund reported 115,177 shares.
Ratings analysis reveals 67% of Halliburton’s analysts are positive. Out of 6 Wall Street analysts rating Halliburton, 4 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $45.0 while the high is $58.0. The stock’s average target of $53.33 is 1.22% above today’s ($52.6877) share price. HAL was included in 6 notes of analysts from October 3, 2016. The rating was initiated by Bernstein with “Outperform” on Friday, December 2. The rating was maintained by FBR Capital with “Outperform” on Friday, October 14. Howard Weil maintained the stock with “Sector Perform” rating in Thursday, October 20 report. The firm has “Market Perform” rating given on Thursday, October 20 by Cowen & Co. The company was initiated on Wednesday, January 18 by SunTrust. Societe Generale upgraded the shares of HAL in report on Monday, October 3 to “Buy” rating.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.